Astellas Pharma Inc. (4503.T)

Tokyo · Healthcare · Drug Manufacturers - General
2,751.50 JPY-0.65%As of 2026-11-22 · JPY
Last session low 2,718.50 JPYLast session high 2,800.00 JPY
52-week low 1,938.50 JPY52-week high 2,800.00 JPY
Market cap (USD)
$31.13B
Sector
Healthcare
P/E (TTM)
12.8x
Dividend yield
2.91%
Next earnings
2027-02-03 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-19 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in JPY.

IndicatorValueReading
RSI (14)67.6In the neutral range (30 to 70)
MACD (12, 26, 9)93.55Above its signal line (82.51); histogram 11.04
Bollinger %B (20, 2)89%Inside the bands (2,413.52 to 2,792.28)
SMA 202,602.90Price is 5.7% above
SMA 502,420.39Price is 13.7% above
SMA 2002,314.64Price is 18.9% above
ATR (20)2.66% of priceAverage true range per day
52-week position94%In the upper part of the 1,938.50 to 2,800.00 range

About Astellas Pharma Inc.

Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

Latest fiscal yearEnded 2026-03-31: revenue of 2.14T JPY and an operating margin of 17.8%.
Next earnings reportExpected on 2027-02-03 (the date is an estimate).

More in Drug Manufacturers - General